A variety ofprokaryotic and eukaryotic host/vector systems are available for the production of large quantities of proteins from cloned genes. For many applications, such as structural analysis, determination of biological specificity, vaccine production, diagnostics, and therapeutics, it may be desirable or even necessary that a recombinant gene product be identical to the natural protein made in vivo. Therefore, not only must a cloned gene be transcribed faithfully and the message translated, but the product must be properly modified, through such processes as glycosylation, cleavage of a signal peptide, disulfide-bridge formation, and proper folding. The development of host/vector systems that will process and modify recombinant proteins, in addition to producing them at high levels, is thus an important prerequisite for the production of such proteins.
Recently, the baculovirus Autographa californica nuclear polyhedrosis virus (AcNPV) was shown to be suitable as a helper-independent, viral expression vector for the efficient production in cultured insect cells of proteins from cloned genes. Human fibroblast interferon (IFN-,/; ref. 1) and a fusion protein between AcNPV polyhedrin and Escherichia coli /3-galactosidase (2) are expressed at very high levels in cells infected with AcNPV recombinant viruses. More important, IFN-P is glycosylated by an N-linked glycan, the pre-IFN-(3 signal polypeptide is removed, and the protein is secreted efficiently (1) . We are undertaking studies to determine how proteins from higher eukaryotes are processed and modified in insect cells infected with AcNPV expression vectors. Such studies will help to determine whether there are fundamental differences between invertebrate and vertebrate cellular mechanisms for protein modification and will provide the information needed to define the advantages and limitations for using baculoviruses as expression vectors.
Human interleukin 2 (IL-2), also referred to as T-cell growth factor, is a lymphokine required for the proliferation of activated T cells and the long-term in vitro growth of certain T-cell lines (3, 4) . The primary structure of the human IL-2 gene product has been deduced from nucleotide sequence analyses of cDNA (5, 6) and genomic (7) (8) (9) clones. IL-2 is first synthesized as a precursor polypeptide of 153 amino acids (5, 6). Taniguchi et al. (5) proposed that cleavage of the 20 amino acid signal peptide results in the production of the mature IL-2 protein, which is secreted into the extracellular fluid. cDNA clones have been used to express recombinant human IL-2 in E. coli (6, 10) and in transfected monkey cells (5) .
Natural IL-2 has been purified to homogeneity from the human T-cell leukemia line Jurkat (11, 12) . Amino acid sequencing of the Jurkat-derived material confirmed the primary structure of the protein, deduced from the cDNA sequence, and established the N-terminal residues after signal peptide cleavage (12, 13) . IL-2 appears to undergo some posttranslational modifications that account for the heterogeneity observed in size and charge (14) . Approximately 40%o of Jurkat-derived IL-2 is not glycosylated (15) . In contrast to earlier reports, the majority of the IL-2 synthesized by normal human peripheral blood lymphocytes appears to be glycosylated (13) . Minor species of IL-2 that are truncated at the N terminus also exist (15) .
Here we describe the production of IL-2 in insect cells, using AcNPV as an expression vector. IL-2 was efficiently produced and the majority of the protein was (1) . pAc373 has a deletion between -9 and +175 and auniqueBamHI site at -9, which is 50 bp downstream from the polyhedrin mRNA cap site (1). quence (5) . A plasmid cDNA clone that contained the entire coding region for human IL-2 (pIL2-2b) was isolated. This clone has been used to express active IL-2 in E. coli (unpublished work). To express IL-2 in insect cells, a 1-kbp BamHI fragment from pIL-2B, which included 31 bp of 5' nontranslated leader sequence, the entire IL-2 coding region, and 309 bp of 3' nontranslated sequence, was excised and inserted into the BamHI site of both pAc373 and pAc380. Recombinant plasmids containing inserts in the correct transcriptional orientation were designated pAc373-IL2 and pAc380-IL2.
Transfer of IL-2 cDNA from these plasmid vectors to the AcNPV genome was achieved by cotransfection, using the calcium phosphate precipitation procedure. Spodoptera frugiperda cells (106) were transfected with a mixture of 2 ,g of pAc373-IL2 or pAc380-IL2 and 1 ,tg of purified AcNPV DNA as described (16) . Three days after transfection, the medium had a virus titer of about 107 plaque forming units (pfu)/ml. Approximately 1% of the plaques from these viral progeny were formed from viruses that did not produce nuclear-viral occlusions (occlusion-negative viruses). Sever (18) . The selected RNA was translated in a wheat germ extract (Bethesda Research Laboratories) or rabbit reticulocyte lysate prepared as described (19) . In certain experiments, dog pancreas membranes (20) were included during translation in a reticulocyte lysate. Purified rotavirus mRNAs were included as a positive control for the protein-modification activity of membranes (20) . Immunoblot analysis was performed as described (21) , with minor modifications. The development of monoclonal anti-IL-2 antibodies will be described in detail elsewhere. Rabbit anti-IL-2 antisera was produced by multiple subdermal injections of recombinant human IL-2 (100 ,ug) mixed in complete Freund's adjuvant. The rabbits were bled 4 and 8 weeks later. Immunoprecipitation with the rabbit anti-IL-2 antisera was done as described (20) .
Assay for IL-2 Activity. The IL-2 activity of the recombinant material was measured by using the IL-2-dependent murine cell line CTLL. The assay was performed in a manner similar to that described in ref. 22 (20 x 4.6 mm, 5-pum particle size) in 10 mM trifluoroacetic acid and eluted with an acetonitrile gradient from 0 to 60% in 1 hr. Automated Edman degradation was carried out on a gas-vapor sequencer, and the resulting phenylthiohydantoin amino acids were analyzed according to a method described by Hawke et al. (23) . RESULTS Production of IL-2 Activity in Insect Cells. The major objectives of this study were to determine whether human IL-2 could be produced at high levels in insect cells using a baculovirus expression vector and whether the pre-IL-2 signal peptide would be correctly removed and the protein secreted from the infected cells. We also wished to examine the importance of the 5' leader sequences of the AcNPV polyhedrin gene in the expression of foreign genes. The first step in cloning IL-2 in AcNPV expression vectors was to insert the human IL-2 coding sequence adjacent to the polyhedrin promoter in the specially constructed plasmid transfer vectors pAc373 and pAc380. A 1-kbp fragment containing a full-length IL-2 cDNA was inserted into the BamHI site at -9 in pAc373 and at -59 in pAc380 (Fig. 1) . The resulting chimeric transfer vectors pAc373-IL2 and pAc380-IL2 were mixed with AcNPV DNA and then coprecipitated with calcium phosphate. S.frugiperda cells were transfected and the resulting viral progeny were screened for the presence of recombinant viruses in which the polyhedrin gene had been inactivated by the insertion of the IL-2 gene fiagment. These recombinants do not form occlusions in infected cells and thus have a distinctive plaque morphology (1, 16) . Restriction analysis of DNA from several of these occlusion-negative viruses confirmed that IL-2 had been transferred to the AcNPV genome and was in the expected location relative to the polyhedrin promoter (data not shown).
Cells infected with Ac373-IL2 and Ac380-IL2 viruses secreted high levels of IL-2 activity into the culture medium (Fig. 2) . Ac380-IL2, in which the IL-2 gene was fused to the polyhedrin promoter at a position that would exclude the polyhedrin 5' leader sequences, produced about one-third the level of IL-2 activity produced in cells infected with Ac373-IL2. The IL-2 sequence in Ac373-IL2 was fused to the polyhedrin promoter at a position such that the hybrid gene would include the majority of the polyhedrin 5' leader sequences. Cells infected with either of these vectors released IL-2 activity into the culture medium up to 72 hpi at which time the infected cells were still intact. In a separate experiment, the intracellular and extracellular levels of IL-2 were measured. At 56 hpi, approximately 67% and 72% of the activity was present in the media of cells infected with Ac373-IL2 and Ac380-IL2, respectively. Since the cells remained intact during infection and the majority of the IL-2 activity was in the medium, IL-2 was most likely being secreted, as opposed to being released as a result of cell lysis. Media samples from uninfected cells and cells infected with AcNPV had no detectable IL-2 activity.
Identification of IL-2 Produced in Infected Cells. In cells infected with AcNPV, polyhedrin was the major cellular protein at 48 and 72 hpi (Fig. 3, lanes 1 and 2) . In cells infected with the recombinant virus Ac373-IL2, polyhedrin was not made and a new Mr 15,500 intracellular polypeptide accumulated (Fig. 3, lanes 3 and 4) . The molecular weight of natural IL-2, as measured by NaDodSO4/PAGE, is reported to be about 15,000 (12, 14) . A Mr 15,500 protein was also secreted and by 72 hpi was one of the major polypeptides present in the medium (Fig. 3, lane 8) . Accumulation of a protein of Mr 15 ,500 was observed in cells infected with Ac380-IL2, but at one-third the level in Ac373-IL2-infected cells (data not shown).
To identify the IL-2 polypeptides being made, Ac373-IL2-infected cells were incubated with [35S]methionine at 36-39 hpi, and then the labeled proteins from the infected cells and the culture medium were immunoprecipitated with IL-2 antiserum. The Mr 15,500 polypeptide detected in stained gels was a major labeled protein in the infected cells (Fig. 4 , lane 1) and in the culture medium (Fig. 4, lane 2) , and this protein was immunoprecipitated with IL-2 antiserum (Fig. 4, lanes 3  and 4) . In immunoprecipitated with IL-2 antiserum (Fig. 4, lane 3) , but only very low levels were detected in the culture medium (Fig. 4, lane 4) .
To investigate whether IL-2 produced in insect cells was glycosylated, Ac373-IL2-infected cells were labeled with tritiated D-mannose, acetyl-D-glucosamine, L-fucose, or Dgalactose. Although each of these labeled sugars was incorporated into one or more infected cell proteins (data not shown), only D-[2-3H]mannose labeled a polypeptide with a molecular weight similar to either of the two recombinant IL-2 proteins (Fig. 4, lane 5) . However, this Mr 16,000 glycoprotein was found only in the infected cells and not in the medium and was not precipitated with IL-2 antiserum (Fig. 4, lane 6) . In addition, when infected cells were labeled with [35S]methionine in the presence or absence of the glycosylation inhibitor tunicamycin, the inhibitor had no effect on the size of either the Mr 15,500 or the Mr 16,000 IL-2 proteins (data not shown), indicating that they did not have N-linked carbohydrates. This finding is consistent with reports that the fraction of IL-2 produced in human Jurkat cells that is glycosylated contains no N-linked oligosaccharides (12, 13, 15) . Overall, these results indicated that the insect-derived recombinant IL-2 was not glycosylated.
The Mr 16,000 IL-2 protein was somewhat larger than the major secreted form of recombinant IL-2 and was present primarily in the cells, suggesting that it might be pre-IL-2. To investigate this possibility, IL-2 mRNA was obtained from the cytoplasmic fraction of Ac373-IL2-infected cells translated in vitro in wheat germ and rabbit reticulocyte translation systems. A Mr 16,000 polypeptide was made in the wheat germ lysate (Fig. 4, lane 7) , and a very low level of Mr 16, 000 polypeptide was synthesized from IL-2 mRNA in the reticulocyte lysate (Fig. 4, lane 8) . Because signal peptides are not cleaved in a wheat germ translation system (24) , only pre-IL-2 would be made. Therefore, the apparent molecular weight of pre-IL-2 in our polyacrylamide gels was (Fig. 4 , lane 10), and this protein was specifically immunoprecipitated with IL-2 antiserum (Fig. 4, lane 9) . Together, these results indicate that the Mr 16,000 recombinant protein is pre-IL2. Because this protein did not accumulate in the cells during infection (Fig. 3) , there was insufficient quantity available for purification and sequence analysis to confirm this hypothesis.
Purification and N-Terminal Sequence Analysis of Recombinant IL-2. Recombinant IL-2 was produced in serum-free medium in a 2-liter suspension-culture fermentor containing Ac373-1L2-infected S. frugiperda cells. IL-2 was partially purified from about 200 ml of culture medium by batch adsorption to silica gel and reversed-phase HPLC. The IL-2 was purified by an additional HPLC step on Suppelcosil LC-308. The IL-2-containing fraction was submitted to Edman degradation. The first 10 amino acids were determined and found to be identical to the N-terminal sequence of mature IL-2 (12, 13) . The analysis ofthe phenylthiohydantoin threonine derivative at the third amino acid residue indicated that the recombinant protein was not glycosylated at this position, as is observed in about 40% ofthe IL-2 isolated from induced Jurkat cells (12, 13) . to both Jurkat-derived and E. coli-synthesized IL-2 (Fig. 5) . The IL-2 species could be detected either by silver stain (Fig.   SA) or 'by immunoblot analysis (Fig. SB) . Analysis in NaDodSO4/polyacrylamide gels revealed that the purified insect-cell material separated into two components, a major species at Mr 15,500 and a minor species at Mr 16,000 (Fig.  5A, lane 1) . The Mr 15,500 species comigrated with purified recombinant E. coli IL-2 (Fig. SA, lanes 5 and 6) and with the major species of IL-2 purified from Jurkat cells (Fig. SA,  lanes 3 and 4) . Immunoblot analysis showed that these components were all immunoreactive with monoclonal anti-IL-2 antibodies (Fig. SB) . The minor components in the Jurkat-derived material, which migrate slightly slower than the major component, may represent variants in glycosylation (14, 15) .
The purified recombinant IL-2 from insect and E. coli cells and purified natural IL-2 from human Jurkat cells were compared for their ability to stimulate the growth of an IL-2 dependent T-cell line. The IL-2 specific activity, measured as described in ref. 22 , for these proteins were between 0.5 and 1.0 x 108 units/mg, or within the factor-of-2 error inherent in this assay.
DISCUSSION
In this study we demonstrated that (i) recombinant IL-2 was expressed at high levels under the transcriptional control of the AcNPV polyhedrin promoter; (it) higher levels of expression were obtained when the IL-2 gene was inserted into an AcNPV expression vector that included the polyhedrin 5' leader sequences; (iii) protein-processing mechanisms within the insect cell recognized the pre-IL-2 signal peptide and cleaved the amino acid sequence at the correct position; and (iv) the majority of the IL-2 was secreted. There was no evidence that the recombinant IL-2 produced in insect cells was glycosylated. However, about 40% of the natural IL-2 produced in human Jurkat cells is not glycosylated (12) , and modifications such as glycosylation do not appear to be required for IL-2 bioactivity (10).
There were two intracellular forms of IL-2 produced in Ac373-IL2-infected cells: a Mr 15,500 protein that was efficiently secreted and a Mr 16,000 protein that was detected primarily in the cells and was the same size as pre-IL-2 synthesized from selected mRNA in a wheat germ extract. The majority of the recombinant IL-2 made in infected cells had the correct N-terminus and was secreted. We assume that it was processed and released from the cell along a secretory pathway similar to the pathway described for vertebrates (25) . That is, nascent chains of IL-2 would be translocated across the endoplasmic reticulum (ER), moved to the Golgi apparatus, and then carried to the plasma membrane by transport vesicles. The targeting of a secretory protein to the ER involves the recognition of the signal peptide, on the nascent polypeptide, by a signal-recognition particle, which arrests translation. If the translation of a nascent IL-2 protein in infected insect cells was not arrested, one would predict that a pre-IL-2 would be synthesized but not translocated across the ER, and therefore, not secreted. One explanation for the presence of the Mr 16,000 IL-2 (presumably pre-IL-2) in Ac373-1L2-infected cells is that the available signal-recognition particles were titrated out by the excess number of pre-IL-2 signal peptides that were being synthesized. If this is true, then there may be an upper limit on the efficiency at which secretory or membrane-bound proteins with signal peptides can be processed in the insect cell/baculovirus vector system.
The amount of IL-2 produced and secreted from Ac373-IL2-infected cells was similar (per ml of medium) to that obtained in an E. coli/plasmid vector system (10) . However, the amino acid sequence of IL-2 made in E. coli is not identical to natural IL-2 because of the addition of a bacterial formylmethionine at the N terminus (10) . In bacterial vectors, it is usually necessary to delete the coding region for signal peptides to express the mature form of eukaryotic genes for proteins, like IL-2, with cleavable signal sequences. In contrast, IL-2 was cloned in the AcNPV expression vector with the IL-2 protein initiation site and signal peptide sequences intact. These signals were recognized in the infected insect cells and IL-2 was produced with a correct N terminus. Apparently, the signals required for signal peptide recognition and processing and protein secretion have been largely conserved between insects and mammals.
